SkinIO Completes Smart Health Innovation Lab Residency Program, Strengthening “Market Readiness” for Skin Cancer Screening Platform

SkinIO, a virtual skin cancer screening platform that allows anyone, anywhere to perform a full body skin exam using their smartphone, is the latest in Smart Health Innovation Lab (iLab), an accelerator for the adoption of health technologies by the market.

SkinIO has now successfully passed the key quality assurance and efficiency standards needed to increase adoption of its technology. SkinIO meets users where they are, providing on-site skin screenings in 10 minutes and allowing users to safely scan and map their skin at home with the SkinIO smartphone app. SkinIO photos and data are securely sent to dermatologists for remote review and recommendation of appropriate follow-up care.

During a pilot program with local employers, the company’s detection protocol uncovered skin cancer risk in several patients. SkinIO has also helped connect users with medical professionals when needed. Working with employers, physicians, and healthcare organizations, SkinIO plans to become more aligned with payers as the value-based care market begins to take shape.

SkinIO is the third company to graduate from iLab’s cutting-edge innovation “immersion” experience, in which providers, payers, investors, patients and clinical experts work together to testing and improving products before they are fully introduced to the market. health market. This year’s cohort focused on teledermatology and improving access to skin cancer screening at a time when preventative examinations have declined, primarily due to the pandemic.

“Our iLab graduates are solving real-world problems, like the lack of accessible, easy-to-use skin cancer screening tools that can save lives,” said Kim Ireland, CEO of Smart Health Innovation Lab. “The iLab is proving to be a leading program for empowering early-stage technologies like SkinIO, using the strength of our alliances in the healthcare landscape to bring healthcare technology to the practice. of the doctor and to the patients.

SkinIO leveraged iLab’s extensive network and clinical, operational, and payer expertise to enhance its product functionality and open doors to new customers. In May, SkinIO collaborated with several Lancaster-based employers to conduct a pilot program. The program helped increase the number of screenings among employees of these companies, 43% of whom had never had a formal skin exam before. Participants responded with a rating of 95% “very satisfied” or “satisfied”.

“We were able to pressure test our technology in a framework that allowed for iterative feedback from end users – patients, employers, payers and clinical leaders with decades of experience – and refine our go-to-market strategy in a way that accelerates our growth schedule,” said Kyoko Crawford, CEO of SkinIO. “Smartphones and digital tools are increasingly essential to expanding access to specialty care like dermatology – access that past generations simply didn’t have. We plan to make virtual skin screening and deployment of AI to analyze data a standard of care.

The Smart Health Innovation Lab focuses on early-stage technologies and diagnostics with commercial viability and unmet market demand. In previous years, iLab has supported companies such as NeuroFlow, Emovi and OneOme, serving as a proving ground for new applications and fostering interoperability in various healthcare settings. Schedules and timelines for the next cohort will be available to applicants in late fall 2022.

About the Smart Health Innovation Lab

Smart Health Innovation Lab, located in Lancaster, Pennsylvania, is a market adoption accelerator designed to test, certify and advance new health technologies. In the lab, payers, providers, and technology companies work together in a unique collaboration to validate and integrate healthcare innovations into the healthcare marketplace. Founded by Aspire Ventures, Capital Blue Cross, Clio Health and Penn Medicine Lancaster General Health, the Smart Health Innovation Lab brings together different healthcare players to achieve a common goal: to improve the health of our communities through new technologies that improve the patient. and provider experience, reduce the cost of care and improve health outcomes. For more information, visit

About SkinIO

SkinIO is an AI-powered, HIPAA-compliant, virtual skin cancer screening platform that allows anyone, anywhere to perform a skin exam in just 10 minutes using his smartphone. SkinIO images are reviewed remotely by expert dermatologists, users receive their results by email in just days, and they are connected to care if they require in-person follow-up. For more information, visit


Share the article on social networks or by e-mail: